Update on the Diagnosis and Management of Gastric Intestinal Metaplasia in the USA

Judy A. Trieu; Mohammad Bilal; Hamzeh Saraireh; Andrew Y. Wang

doi:10.1007/s10620-019-05526-5

Update on the Diagnosis and Management of Gastric Intestinal Metaplasia in the USA

Judy A. Trieu
, Mohammad Bilal
, Hamzeh Saraireh
, Andrew Y. Wang

Division of Gastroenterology

Research output: Contribution to journal › Review article › peer-review

20 Scopus citations

Abstract

Gastric intestinal metaplasia (GIM) is a premalignant condition that can lead to intestinal-type gastric adenocarcinoma. It is characterized by a change in the gastric mucosa to a small-intestinal phenotype. Infection with Helicobacter pylori is the most common factor associated with GIM. Although GIM is typically a histologic diagnosis, various techniques have been developed to enable the endoscopic identification of GIM. There are presently no widely accepted guidelines on screening and surveillance strategies in patients with GIM in the USA. The aim of this review is to provide an update regarding the problem, diagnosis, and management of GIM in the USA.

Original language	English
Pages (from-to)	1079-1088
Number of pages	10
Journal	Digestive diseases and sciences
Volume	64
Issue number	5
DOIs	https://doi.org/10.1007/s10620-019-05526-5
State	Published - May 15 2019

Keywords

Early gastric cancer
Gastric adenocarcinoma
Gastric intestinal metaplasia
Helicobacter pylori

Access to Document

10.1007/s10620-019-05526-5

Cite this

@article{4d42b274b3c644d4872905cb809cdbc2,

title = "Update on the Diagnosis and Management of Gastric Intestinal Metaplasia in the USA",

abstract = "Gastric intestinal metaplasia (GIM) is a premalignant condition that can lead to intestinal-type gastric adenocarcinoma. It is characterized by a change in the gastric mucosa to a small-intestinal phenotype. Infection with Helicobacter pylori is the most common factor associated with GIM. Although GIM is typically a histologic diagnosis, various techniques have been developed to enable the endoscopic identification of GIM. There are presently no widely accepted guidelines on screening and surveillance strategies in patients with GIM in the USA. The aim of this review is to provide an update regarding the problem, diagnosis, and management of GIM in the USA.",

keywords = "Early gastric cancer, Gastric adenocarcinoma, Gastric intestinal metaplasia, Helicobacter pylori",

author = "Trieu, \{Judy A.\} and Mohammad Bilal and Hamzeh Saraireh and Wang, \{Andrew Y.\}",

note = "Publisher Copyright: {\textcopyright} 2019, Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2019",

month = may,

day = "15",

doi = "10.1007/s10620-019-05526-5",

language = "English",

volume = "64",

pages = "1079--1088",

journal = "Digestive diseases and sciences",

issn = "0163-2116",

number = "5",

}

TY - JOUR

T1 - Update on the Diagnosis and Management of Gastric Intestinal Metaplasia in the USA

AU - Trieu, Judy A.

AU - Bilal, Mohammad

AU - Saraireh, Hamzeh

AU - Wang, Andrew Y.

PY - 2019/5/15

Y1 - 2019/5/15

N2 - Gastric intestinal metaplasia (GIM) is a premalignant condition that can lead to intestinal-type gastric adenocarcinoma. It is characterized by a change in the gastric mucosa to a small-intestinal phenotype. Infection with Helicobacter pylori is the most common factor associated with GIM. Although GIM is typically a histologic diagnosis, various techniques have been developed to enable the endoscopic identification of GIM. There are presently no widely accepted guidelines on screening and surveillance strategies in patients with GIM in the USA. The aim of this review is to provide an update regarding the problem, diagnosis, and management of GIM in the USA.

AB - Gastric intestinal metaplasia (GIM) is a premalignant condition that can lead to intestinal-type gastric adenocarcinoma. It is characterized by a change in the gastric mucosa to a small-intestinal phenotype. Infection with Helicobacter pylori is the most common factor associated with GIM. Although GIM is typically a histologic diagnosis, various techniques have been developed to enable the endoscopic identification of GIM. There are presently no widely accepted guidelines on screening and surveillance strategies in patients with GIM in the USA. The aim of this review is to provide an update regarding the problem, diagnosis, and management of GIM in the USA.

KW - Early gastric cancer

KW - Gastric adenocarcinoma

KW - Gastric intestinal metaplasia

KW - Helicobacter pylori

UR - https://www.scopus.com/pages/publications/85061659295

U2 - 10.1007/s10620-019-05526-5

DO - 10.1007/s10620-019-05526-5

M3 - Review article

C2 - 30771043

AN - SCOPUS:85061659295

SN - 0163-2116

VL - 64

SP - 1079

EP - 1088

JO - Digestive diseases and sciences

JF - Digestive diseases and sciences

IS - 5

ER -

Update on the Diagnosis and Management of Gastric Intestinal Metaplasia in the USA

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this